(Alliance News) - GSK PLC on Wednesday reported better-than-expected earnings, largely driven by improved margins and lower costs, although sales growth was limited by a weaker-than-hoped performance in its Vaccines division. Read More
(Alliance News) - Stock prices in London opened lower on Wednesday, as investors braced for Chancellor John Healey's first budget and the US Federal Reserve's interest rate decision, while losses for GSK and Unilever weighed on the FTSE 100. Read More
(Alliance News) - GSK reports a fall in third-quarter profit despite higher revenue, while Unilever upgrades its full-year volume growth outlook. Aston Martin narrows its third-quarter loss as revenue jumps, driven by deliveries of its Valhalla supercar. Read More
(Alliance News) - Computacenter raises its full-year profit outlook after strong third-quarter trading, while Plus500 forecast annual revenue and earnings ahead of market expectations. GSK has reported positive clinical trial results for two cancer treatments. Read More
(Alliance News) - GSK PLC on Wednesday noted five-year data for ViiV Healthcare's HIV treatment Cabenuva, which the lead study author found "highly encouraging". Read More
(Alliance News) - GSK PLC on Wednesday announced US regulatory approval for its chronic hepatitis B treatment Hibsago, while Hutchmed China Ltd confirmed the completion of a separate licensing agreement with GSK worth up to USD1.30 billion. Read More
(Alliance News) - Fresnillo says it has maintained its annual production forecast, GSK has landed a US drug approval and Quilter reports its net inflows for the year have already topped 2025's level. Meanwhile, drilling at a North Sea gas field co-owned by Shell has been approved. Read More
(Alliance News) - LondonMetric reports growth in rental income over its first half, GSK posts promising results from a drug trial while Volex expects annual profit at the upper end of market forecasts. Meanwhile, Abenojar Tungsten, set to list later this month, could be worth more than GBP600 million. Read More
(Alliance News) - The FTSE 100 ended higher on Wednesday, despite strong US inflation data, as the Bank of England's chief economist played down fears of multiple interest rate rises in the UK. Read More
(Alliance News) - The FTSE 100 ended higher on Wednesday, despite strong US inflation data, as the Bank of England's chief economist played down fears of multiple interest rate rises in the UK. Read More
(Alliance News) - Stock prices in London were higher at midday on Tuesday, as pharmaceutical stocks advanced and investors digested UK mortgage data showing approvals at their lowest level since the end of 2023. Read More